“Once you have been diagnosed with cirrhosis, you should get ultrasounds to surveil for tumors,” said Hassan Aziz, MD, FACS, a transplant and hepatobiliary surgeon at University of Iowa Healthcare, describing patients who arrive with ruptured liver cancers that were curable months earlier.
A study published this week in the Journal of the American College of Surgeons found that 1,430 U.S. counties—45 percent of the total—lack a single general surgeon, surgical oncologist, or colorectal surgeon, leaving 26.6 million residents in gastrointestinal and hepatopancreatobiliary (GI/HPB) surgical deserts, Mirage News reported.
Colorectal cancer mortality remains 6 percent higher in these deserts even after adjusting for poverty, rurality, and cancer incidence, and death rates for pancreatic and hepatobiliary cancers are also significantly elevated.
The cross-sectional ecological analysis linked the 2025 CMS Doctors and Clinicians roster with NCI/CDC State Cancer Profiles, the Area Deprivation Index, 2023 Rural-Urban Continuum Codes, and 2020 Census data across all 3,144 counties representing 331 million people. Surgical desert counties were smaller, more deprived, and less likely to have a hospital (55 percent versus 95 percent), yet 13.5 million affected residents live in metropolitan areas, Newswise reported.
“Just having a surgeon may not lead to good outcomes alone. We need a team—primary care physicians, hepatologists, and people who can get you screened,” Dr. Aziz told Mirage News. Among counties that already had a surgeon, density did not correlate with colorectal cancer mortality, suggesting that the presence of a surgical backbone enables the broader care continuum—screening, diagnosis, and multidisciplinary management—rather than operative volume alone.
Geography Dictates Survival in Surgical Deserts
- Geography dictates survival: Living in a county without a cancer surgeon raises your risk of dying from colorectal, pancreatic, and liver cancers, regardless of income or urban status.
- Screening gaps drive late diagnosis: Cancers requiring specialist infrastructure for detection—pancreatic, hepatobiliary, gastric, esophageal—show excess late-stage diagnosis in deserts; screen-detected colorectal cancer does not.
- One surgeon anchors a system: Mortality plateaus once a county has at least one surgeon, because that clinician typically catalyzes the referral network, tumor boards, and surveillance pathways.
Desert Definition Shows Persistent Mortality Gap
Researchers defined a GI/HPB surgical desert as a county with zero in-county general surgeons, surgical oncologists, or colorectal surgeons. Before adjustment, colorectal cancer mortality was 28 percent higher in desert counties; after controlling for Area Deprivation Index, rurality, region, and incidence, the excess persisted at 6 percent. Model-predicted adjusted mortality was 13.6 per 100,000 in deserts versus 12.9 per 100,000 in surgeon-present counties—a relative difference of 5.8 percent.
Case-fatality rates (deaths among diagnosed patients) were also higher in deserts: colorectal +1.3 percent, pancreatic +3.4 percent, and hepatobiliary +3.8 percent. Excess late-stage diagnosis was confined to cancers lacking standardized screening pathways: pancreatic (+1.9 percent), hepatobiliary (+4.6 percent), gastric (+5.8 percent), and esophageal (+3.3 percent). For colorectal cancer, stage distribution and guideline-concordant screening rates were equivalent across desert and non-desert counties.
| Cancer Site | Adjusted Mortality Increase in Deserts | Excess Late-Stage Diagnosis | Case-Fatality Increase |
|---|---|---|---|
| Colorectal | ~6% | None (screening-dependent) | +1.3% |
| Pancreatic | Significant | +1.9% | +3.4% |
| Hepatobiliary | Significant | +4.6% | +3.8% |
| Gastric | Not reported | +5.8% | Not reported |
| Esophageal | Not reported | +3.3% | Not reported |
Surveillance Failure in Cirrhosis
Dr. Aziz highlighted a sentinel failure: patients with cirrhosis—the primary risk factor for hepatocellular carcinoma—who never received guideline-recommended six-month surveillance ultrasounds. “These patients could have had curative transplant or surgery, but now the tumor has ruptured and spilled everywhere, and curing is no longer an option,” he told Mirage News.
The American Association for the Study of Liver Diseases and National Comprehensive Cancer Network both recommend biannual ultrasound with or without alpha-fetoprotein testing for cirrhotic patients, yet adherence remains low in resource-poor settings.
Workforce Policy and System Integration
The authors outline three policy levers: strengthening surgical recruitment and retention through loan repayment and rural track residencies; building regional referral networks with formalized care-coordination agreements between critical-access hospitals and NCI-designated cancer centers; and expanding satellite clinics, mobile endoscopy units, and telemedicine pre-operative evaluation. Dr. Aziz cautioned that telemedicine alone cannot bridge the gap for older, less tech-literate patients or those without broadband.
“Simply adding a surgeon is not going to solve everything. We need to address the whole access-to-care issue,” Dr. Aziz told Mirage News. “Where someone lives should not determine the opportunity to timely, high-quality care.” The 2026 ACS surgical workforce map previously documented 15 million Americans in counties with no general surgeon; this analysis extends that deficit to the subspecialty oncology workforce.
Study Limitations
The ecological design cannot confirm that individuals who died lacked access to a local surgeon. The CMS clinician file may misclassify surgeons practicing across county lines or on a locum basis. Travel time and distance to the nearest surgeon were not computed; future geospatial analyses incorporating drive-time isochrones are planned.
University of Iowa Health Care traces its foundation to 1898 and operates with the stated mission “Changing Medicine. Changing Lives.” In the 2026 SCImago Institutions Rankings, it placed 2,198th worldwide and 35th among U.S. health-sector organizations overall, with a research percentile of 29th and an innovation percentile of 31st within the health sector. Its surgery specialty ranked 152nd nationally across all sectors.
Co-authors Faisal S. Jehan, MD, FSSO; Brian C. Longbottom, MD; Keely Kringlen, MD, MPH; and Sean Y. Kim, BS reported no relevant financial conflicts.
References
- Jehan FS, Longbottom BC, Kringlen K, et al. Gastrointestinal and Hepatopancreatobiliary Cancer Surgical Deserts and Population Cancer Mortality: A National County-Level Analysis. 2026.
- American College of Surgeons. Surgical Workforce Map 2026. Chicago, IL: ACS; 2026.
- Singal AG, Lampertico P, Nahon P. Surveillance for Hepatocellular Carcinoma. 2023;389(10):928-939.
- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. Version 2.2024.
- U.S. Centers for Medicare & Medicaid Services. Doctors and Clinicians Data. 2025 release.